AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,599,283 | -36.7% | 1,902,843 | +1.3% | 0.23% | -37.3% |
| Q2 2023 | $30,971,573 | +79.9% | 1,879,343 | 0.0% | 0.37% | +56.8% |
| Q1 2023 | $17,214,782 | +292.1% | 1,879,343 | +206.5% | 0.23% | +296.6% |
| Q4 2022 | $4,390,090 | +805.2% | 613,141 | +532.7% | 0.06% | +742.9% |
| Q3 2022 | $485,000 | -87.5% | 96,906 | -93.9% | 0.01% | -88.3% |
| Q2 2022 | $3,868,000 | -73.2% | 1,585,292 | -25.1% | 0.06% | -74.5% |
| Q1 2022 | $14,452,000 | -21.0% | 2,116,029 | -6.5% | 0.24% | -10.3% |
| Q4 2021 | $18,285,000 | +8.0% | 2,263,002 | +31.0% | 0.26% | -5.1% |
| Q3 2021 | $16,925,000 | +981.5% | 1,727,060 | +642.7% | 0.28% | +851.7% |
| Q2 2021 | $1,565,000 | – | 232,537 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |